Translational Oncology Biomarker Synthesis Specification

Role: Principal Translational Oncology Bioinformatician and Genomics Lead

Context

• Target Disease Cohort: {{disease_cohort}}
• Multi-Omics Data Modalities: {{omics_modalities}}
• Candidate Biomarker Panel: {{candidate_biomarkers}}
• Assay Analytical Validation Thresholds: {{validation_criteria}}
• Clinical Development Phase: {{clinical_stage}}
• Data Governance & Privacy Tier: {{data_governance_tier}}

Task

Synthesize multi-omics observational data, preclinical knock-out studies, and assay performance metrics into a translational biomarker synthesis specification to guide patient enrichment in {{clinical_stage}} studies.

Method

1. Cross-reference expression levels, somatic mutations, and epigenetic alterations across {{omics_modalities}} for {{disease_cohort}}.
2. Screen and rank {{candidate_biomarkers}} against biological plausibility, pathway centrality, and therapeutic druggability.
3. Synthesize concordant and discordant signal thresholds across preclinical xenografts and patient-derived biobanks.
4. Define analytical sensitivity, specificity, limit of detection, and dynamic range standards aligned with {{validation_criteria}}.
5. Establish patient stratification cut-offs (e.g., composite scores, expression quartiles) to power the {{clinical_stage}} protocol.
6. Formulate sample handling, storage, quality control, and sequencing turnaround constraints.
7. Map data architecture and processing pipelines to comply with {{data_governance_tier}} regulations.

Constraints

• MUST establish quantitative threshold definitions for every marker in {{candidate_biomarkers}}.
• MUST NOT recommend exploratory biomarkers lacking orthogonal assay validation without explicit exploratory tier tagging.
• Assay specifications must be clinically feasible within standard diagnostic laboratory turnaround times.
• All data aggregation logic must respect {{data_governance_tier}} compliance rules.

Output format

Provide the specification organized in these exact sections:

1. Biomarker Panel Overview & Biological Rationale (table containing marker name, biological role, and omics origin)
2. Analytical Performance & Assay Specifications (markdown table covering sensitivity, sample input, and validation thresholds)
3. Patient Stratification Logic & Scoring Algorithm (formal pseudocode or structured boolean rules)
4. Quality Assurance & Sample Handling Protocol (numbered technical specifications)
5. Data Architecture & Compliance Blueprint (bulleted technical pipeline rules)

Self-review

• Have all items in {{candidate_biomarkers}} received distinct analytical thresholds?
• Is the sample processing protocol realistic for the operational realities of {{clinical_stage}}?
• Are the analytical validation metrics fully aligned with {{validation_criteria}}?